UPDATE
: Monday, December 9, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Novartis Korea gains approval for skin disease biologic
The Ministry of Food and Drug Safety (MFDS) has approved biologic Xolair to...
by Marian Chu
|
2017-09-07 14:28
라인
Green Cross Cell, Maryland to cooperate for US business
Green Cross Cell, a cell treatment company, announced Wednesday that it has...
by Lee Han-soo
|
2017-09-07 11:18
라인
BMS, Pfizer prove safety for blood-thinning drug in P4 trial
Bristol-Myers Squibb and Pfizer said Wednesday their blood thinner drug Eli...
by Marian Chu
|
2017-09-06 17:40
라인
Novartis’ Revolade proved effective for seniors
Novartis Korea said Tuesday additional data analysis from its EXTEND clinic...
by Marian Chu
|
2017-09-06 12:53
라인
GemVax & KAEL names Song as new CEO
GemVax & KAEL has appointed Song Hyoung-gon 송형곤 as their new chief executiv...
by Lee Han-soo
|
2017-09-06 10:47
라인
Will Amgen’s Repatha succeed in the Korean market?
Amgen Korea released its cholesterol-lowering drug Repatha in the domestic ...
by Marian Chu
|
2017-09-06 09:07
라인
Pfizer Korea releases new tool for rheumatism injection
Pfizer Korea said Tuesday it has released an injection tool and program cal...
by Marian Chu
|
2017-09-05 17:22
라인
‘Mooncare’ helps bio, pharmaceutical stocks overcome NK risks
Amid escalating North Korea risks caused by the North’s nuclear and missile...
by Nam Doo-hyun
|
2017-09-05 16:45
라인
Celgene Korea names new CEO
Celgene Korea has elected Ham Tae-jin as its new CEO, the company said Tues...
by Marian Chu
|
2017-09-05 14:22
라인
Korean start-up Sky Labs wins in Bayer innovation program
Bayer (CEO: Werner Baurmann) said Tuesday it selected four startups, includ...
by Marian Chu
|
2017-09-05 11:11
라인
Ahngook gets state support for new drug
Ahngook Pharmaceuticals said Tuesday it has secured the government’s suppor...
by Lee Han-soo
|
2017-09-05 10:53
라인
Celgene’s leukemia drug gets extended insurance coverage
Celgene said Monday its myelodysplastic syndrome (MS) treatment Vidaza (Ing...
by Lee Han-soo
|
2017-09-04 17:34
라인
Korea UCB gets approval for hemophilia treatment
Korea UCB (CEO: Lee Young-joo) said Tuesday the Ministry of Food and Drug S...
by Marian Chu
|
2017-09-04 15:32
라인
Bluegreen, Haim Bio sign strategic alliance agreement
Haim Bio 하임바이오, a venture company for new bio drugs, entered into a strateg...
by Lee Han-soo
|
2017-09-04 15:11
라인
Roche gets insurance coverage for pregnancy complication detection test
Roche Diagnostics Korea said its blood test for a pregnancy complication ca...
by Marian Chu
|
2017-09-04 11:45
라인
CJ Healthcare submits new drug application for Tegoprazan
CJ Healthcare said Monday it has submitted new drug application with the Mi...
by Lee Han-soo
|
2017-09-04 11:32
라인
Eisai gets insurance coverage for thyroid cancer drug
Eisai Korea said Friday its thyroid cancer treatment Lenvima (ingredient: l...
by Marian Chu
|
2017-09-01 13:59
라인
Quratis applies for P2 clinical trial for Korea’s first adult tuberculosis vaccine
Quratis announced Wednesday that the company had applied for the phase 2 of...
by Lee Han-soo
|
2017-09-01 12:04
라인
Gilead, Yuhan to jointly promote hepatitis C drugs
Gilead Sciences Korea and Yuhan Corporation said Thursday the two companies...
by Marian Chu
|
2017-08-31 17:08
라인
Abbvie gets approval for phase 3 clinical trials to treat Crohn’s disease
Abbvie’s new drug Risankizumab, being developed to treat the Crohn’s diseas...
by Lee Hye-seon
|
2017-08-31 15:49
-
이전
81
82
83
84
85
86
87
88
89
90
-
Celltrion unveils long-term P3 trial results for Truxima in US
AMC unravels clues in treating relapsing, metastatic bladder cancer
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
AbbVie’s Venclexta nears insurance benefit
Celltrion unveils long-term P3 trial results for Truxima in US
AMC unravels clues in treating relapsing, metastatic bladder cancer
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
AbbVie’s Venclexta nears insurance benefit
여백
Most viewed
1
Technology developed to detect inflammatory disorders early
2
'Insulin is safe, natural replacement therapy for diabetic patients'
3
Roche Diabetes Care stresses ‘integrated personalized diabetes management’
4
Samyang Biopharm’s US subsidiary to work on new immunotherapy
5
Swedish researchers divide Type 2 diabetes into 5 subgroups
6
Ildong signs co-promotion contract with GSK Consumer Healthcare
7
Korean patient with rare breast cancer to sue Allergan in US
8
Korea exports health insurance system to Bahrain
9
Quick test for meningitis unavailable due to low reimbursement
10
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
여백
Opinion
[Column] Korea should do better in diabetes management
[Column] Digital healthcare for efficient distribution of medical resources
[Reporter’s Notebook] SillaJen should be ashamed of itself
여백
Back to Top